TNFRSF1B and cancer: Similarly, a recombinant vector pMCSG7-hsTNF-R2 was constructed to generate human soluble TNF-R2 recombinant protein, which was expected to be used as an immunotherapy drug for TNF-R2+ cancer in an in vitro bioactivity evaluation [181].